Trial Profile
A study evaluating efficacy of Fampridine in patients with inflammatory demyelination of the peripheral nervous system.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Therapeutic Use
- 05 Feb 2018 New trial record